Company / Tangible Book Value per Share
BioMarin Pharmaceutical Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$30.63
FY2025
5-year range
$22.39 / $30.63
FY2021-FY2025
Trend
+7.0%
vs FY2024
Sector context
#13 of 209
Health Care
What the data says
Among 209 Health Care companies, BioMarin Pharmaceutical is in the top 6% for tangible book value per share. Tangible Book Value per Share has increased for 8 consecutive years, from $14.85 in FY2017 to $30.63 in FY2025.
Based on SEC 10-K filings.
30.63 in FY2025 with a 5-year CAGR of +7.4%. Top quartile in the Health Care sector.
Improved from $25.21 to $30.63 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +9.0%
- 5-Year CAGR
- +7.4%
- 10-Year CAGR
- -
Sector benchmark
-67.2% below sector average
Key checks
Key Insights
- BioMarin Pharmaceutical's tangible book value per share has grown for 8 consecutive years.
- In FY2025, tangible book value per share increased 7.0% year-over-year.
- Ranks #13 out of 209 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $30.63 | +7.0% |
| FY2024 | $28.63 | +13.6% |
| FY2023 | $25.21 | +6.6% |
| FY2022 | $23.66 | +5.7% |
| FY2021 | $22.39 | +4.2% |
| FY2020 | $21.49 | +32.1% |
| FY2019 | $16.27 | +4.6% |
| FY2018 | $15.54 | +4.7% |
| FY2017 | $14.85 | -0.2% |
| FY2016 | $14.88 | +9.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026